Navigation Links
Could the humble sea urchin hold the key to carbon capture?
Date:2/4/2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 4, 2015  BioClinica®, Inc., a leading ... today announced that clinical trial professionals representing ... its annual European User Conference in ... the use of its eClinical technologies to ... include: the Microsoft Office-Smart OnPoint CTMS; Express ...
(Date:3/4/2015)... 4, 2015 Launched by ... in December 2011, ,SARAH, - the ... microspheres versus sorafenib in advanced hepatocellular carcinoma (HCC) has ...   SARAH, a large French study of ... or HCC) has completed patient enrolment, exceeding its 400-patient ...
(Date:3/3/2015)... - Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS), a ... target the underlying mechanisms of cancer, today reported financial ... 31, 2014. Effective July 17, 2014, the ... to December 31. As a result of that change, ... quarter and the seven months ended December 31, 2014, ...
(Date:3/3/2015)... 03, 2015 Experts and industry insiders ... one event: the Alltech REBELation exploring innovation, inspiration and ... Now in its 31st year, Alltech’s annual international conference ... and the opportunity to join the REBELation at an ... 11:59 p.m. EST, at which point the standard early ...
Breaking Biology Technology:BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 2BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 3Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 2Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 3Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 4Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 2Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 3Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 4Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 6Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 7Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 8Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 9Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 10Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 11Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 12World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 2World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 3World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 4
... Family practice, inevitably the most prominent healthcare specialty, is ... increase in the number of patients, with Texas, Florida and ... Family practice physicians in the US. MBC, with a huge ... in Dallas, expects to fulfill the increasing demand for administrative ...
... ReportsnReports   announces it will carry ... markets (industries) of Belgium in its store A. ... market is expected to grow from $99.6 billion in 2010 to $162.2 ... EMR is expected to be the highest growing market with ...
... and TOKYO, Aug. 15, 2011 A new post-hoc ... TRITON-TIMI 38 study – those identified as the "core ... (in combination with aspirin) was associated with a 26 ... of cardiovascular death, myocardial infarction or stroke, compared to ...
Cached Biology Technology:MBC has the Highest Number of Medical Billers and Coders in Dallas, Texas Servicing Primary Healthcare Physicians 2MBC has the Highest Number of Medical Billers and Coders in Dallas, Texas Servicing Primary Healthcare Physicians 3MBC has the Highest Number of Medical Billers and Coders in Dallas, Texas Servicing Primary Healthcare Physicians 4MBC has the Highest Number of Medical Billers and Coders in Dallas, Texas Servicing Primary Healthcare Physicians 5ReportsnReports - Healthcare IT Market, Electric Buses & Taxis, Belgium Market Research 2ReportsnReports - Healthcare IT Market, Electric Buses & Taxis, Belgium Market Research 3ReportsnReports - Healthcare IT Market, Electric Buses & Taxis, Belgium Market Research 4Effient® (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopidogrel in New Core Clinical Cohort Population Sub-Analysis of the TRITON-TIMI 38 Pivotal Study 2Effient® (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopidogrel in New Core Clinical Cohort Population Sub-Analysis of the TRITON-TIMI 38 Pivotal Study 3Effient® (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopidogrel in New Core Clinical Cohort Population Sub-Analysis of the TRITON-TIMI 38 Pivotal Study 4Effient® (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopidogrel in New Core Clinical Cohort Population Sub-Analysis of the TRITON-TIMI 38 Pivotal Study 5Effient® (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopidogrel in New Core Clinical Cohort Population Sub-Analysis of the TRITON-TIMI 38 Pivotal Study 6Effient® (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopidogrel in New Core Clinical Cohort Population Sub-Analysis of the TRITON-TIMI 38 Pivotal Study 7Effient® (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopidogrel in New Core Clinical Cohort Population Sub-Analysis of the TRITON-TIMI 38 Pivotal Study 8
(Date:2/5/2015)... , Feb. 5, 2015  Marken is starting its ... and has launched a new marketing campaign to solidify ... (CLO).  The new campaign focuses on First ... and shipments. The first headline in the ... Marken,s priorities with its client,s priorities. Marken recognizes the ...
(Date:2/5/2015)... 28, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce ... Global Online CEO Conference on January 29 th ... Pereira , CEO of NXT-ID will present and host ... Wocket smart wallet and its full suite of biometric ...
(Date:1/22/2015)... 9, 2015 Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ON), is ... the State of Washington,s Department of ... enrollment and central issuance system for driver,s licenses and identification ... project planning and development will start in January 2015, with ...
Breaking Biology News(10 mins):Marken Launches New Patient-Centric Campaign 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3Valid USA Signs Contract For Washington Driver's License Issuance 2
... which trauma and burn patients are most likely to ... range of experimental clinical settings ?an important hurdle to ... rooms and intensive care units. , In a report ... National Academy of Sciences, researchers from eight institutions, including ...
... of California, San Diego (UCSD) have found that Lafora disease, ... the age of 30, can be caused by mutations in ... These findings are reported in the current issue of Proceedings ... is characterized by normal development for the first decade of ...
... comparing, for the first time, breast cancers from Nigeria, ... African ancestry are more likely to be diagnosed with ... of European ancestry. , Researchers from the University of ... in Nigeria and the University of North Carolina, found ...
Cached Biology News:Doctors closer to using gene analysis to help trauma patients 2Doctors closer to using gene analysis to help trauma patients 3UCSD research reveals mechanism involved with type of fatal epilepsy 2Study reveals dramatic difference between breast cancers in US and Africa 2Study reveals dramatic difference between breast cancers in US and Africa 3Study reveals dramatic difference between breast cancers in US and Africa 4
casein kinase 2, alpha 1 polypeptide, transcript variant 2, mRNA (cDNA clone MGC:15232 IMAGE:4121882), complete cds...
UV LAMP 254 NM 8 WATT, 1 EA. Category: Nucleid Acid Detection Systems....
... Fluor 488 Cytochrome c Apoptosis Detection Kit ... detect cytochrome c in fixed cells. The ... antibody and an Alexa Fluor 488 dye-labeled ... bright green fluorescence that is compatible with ...
MOUSE ANTI NEUROFILAMENTS 140+160 KD...
Biology Products: